Determining host factors contributing to disease severity in a family cluster of 29 hospitalized SARS-CoV-2 patients: Could genetic factors be relevant in the clinical course of COVID-19?
- PMID: 32492209
- PMCID: PMC7300487
- DOI: 10.1002/jmv.26106
Determining host factors contributing to disease severity in a family cluster of 29 hospitalized SARS-CoV-2 patients: Could genetic factors be relevant in the clinical course of COVID-19?
Abstract
In this study, we report a large family cluster consisting of 29 genetically related patients hospitalized with coronavirus disease-2019 (COVID-19). We sought to determine the clinical characteristics relevant to the clinical course of COVID-19 by comparing the family cluster to unrelated patients with SARS-CoV-2 infection so that the presence of potential determinants of disease severity, other than traditional risk factors previously reported, could be investigated. Twenty-nine patient files were investigated in group 1 and group 2 was created with 52 consecutive patients with COVID-19 having age and gender compatibility. The virus was detected for diagnosis. The clinical, laboratory and imaging features of all patients were retrospectively screened. Disease course was assessed using records regarding outcome from patient files retrospectively. Groups were compared with respect to baseline characteristics, disease severity on presentation, and disease course. There was no difference between the two groups in terms of comorbidity and smoking history. In terms of inhospital treatment, use differed not significantly between two groups. We found that all 29 patients in the group 1 had severe pneumonia, 18 patients had severe pneumonia. Hospitalization rates, length of hospital stay, and transferred to intensive care unit were found to be statistically significantly higher in the group 1. In the present study, COVID-19 cases in the large family cluster were shown to have more severe disease and worse clinical course compared with consecutive patients with COVID-19 presenting to the same time. We believe further studies into potential genetic mechanisms of host susceptibility to COVID-19 should include such family clusters.
Keywords: COVID-19; family cluster; pneumonia; severity.
© 2020 Wiley Periodicals LLC.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures



Similar articles
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy.Turk J Med Sci. 2022 Apr;52(2):522-523. doi: 10.55730/1300-0144.5341. Epub 2022 Apr 14. Turk J Med Sci. 2022. PMID: 36161620 Free PMC article.
-
[Evaluation of Patients Diagnosed with COVID-19 in Terms of Risk Factors].Mikrobiyol Bul. 2020 Oct;54(4):575-582. doi: 10.5578/mb.69811. Mikrobiyol Bul. 2020. PMID: 33107286 Turkish.
-
Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity.Hum Genomics. 2020 Oct 22;14(1):40. doi: 10.1186/s40246-020-00290-4. Hum Genomics. 2020. PMID: 33092637 Free PMC article. Review.
-
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270. JAMA Netw Open. 2020. PMID: 32543702 Free PMC article. Review.
Cited by
-
The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7).Addiction. 2021 Jun;116(6):1319-1368. doi: 10.1111/add.15276. Epub 2020 Nov 17. Addiction. 2021. PMID: 33007104 Free PMC article. Review.
-
The Role of Host Genetic Factors in Coronavirus Susceptibility: Review of Animal and Systematic Review of Human Literature.Am J Hum Genet. 2020 Sep 3;107(3):381-402. doi: 10.1016/j.ajhg.2020.08.007. Epub 2020 Aug 12. Am J Hum Genet. 2020. PMID: 32814065 Free PMC article.
-
Organoid and microfluidics-based platforms for drug screening in COVID-19.Drug Discov Today. 2022 Apr;27(4):1062-1076. doi: 10.1016/j.drudis.2021.12.014. Epub 2021 Dec 23. Drug Discov Today. 2022. PMID: 34954328 Free PMC article. Review.
-
Human genetic basis of coronavirus disease 2019.Signal Transduct Target Ther. 2021 Sep 20;6(1):344. doi: 10.1038/s41392-021-00736-8. Signal Transduct Target Ther. 2021. PMID: 34545062 Free PMC article. Review.
-
Where are we with understanding of COVID-19?Adv Biol Regul. 2020 Aug;77:100745. doi: 10.1016/j.jbior.2020.100745. Epub 2020 Jul 21. Adv Biol Regul. 2020. PMID: 32773101 Free PMC article. Review.
References
-
- World Health Organization . Coronavirus disease 2019 (COVID‐1) Situation Report‐83. https://who.int
-
- World Health Organization Clinical management of severe acute respiratory infection (SARI) when COVID‐19 disease is suspected: interim guidance, 13 March 2020. World Health Organization; 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous